AbCellera Enters into a Collaboration and License Agreement with Salipro to Boost Therapeutic Antibodies
Shots:
- Salipro to receive an up front- research payments and is eligible for a downstream milestones for several targets
- The collaboration will allow AbCellera to access Salipro Biotech's expertise and its platform to produce stable Ag of membrane protein drug targets in drug discovery programs for therapeutic Abs
- Salipro Biotech has signed multiple research collaborations with pharma and biotech companies. Salipro will be responsible to accelerates the novel drugs discovery
| Ref: PR Newswire | Image: PR Newswire
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com